Expression in patient subsets: Fredlyet al. [39] described decreased expression for elderly patients with CD14+ AML cells, whereas Kornblauet al. [40] described lower levels in younger patients with low-risk cytogenetic abnormalities. This evidence concerns the gene CD14 and acute myeloid leukemia.